ERBB2 and breast cancer: Furthermore, BC can be categorized into different subtypes based on the immunohistochemical analysis of the molecular markers, such as basal-like, HER2+, luminal A, and luminal B. Single-cell RNA sequencing can categorize the BC subtypes in more detail (Sun et al., 2017).